October 27, 2011
According to the RepTrack Survey conducted by ANTERIO Inc. in September (September 5-26), AstraZeneca K.K. (AZ)'s proton pump inhibitor (PPI) Nexium (esomeprazole) launched in September rose to the top in the HP (medical institutions with 100 or more beds) market,...read more